Genexia maintains a narrowly scoped product portfolio centered on the DRGOS operating system, a modestly represented entry in the vulnerability landscape. The durable signal from reported disclosures centers on command-injection weaknesses, reflecting input-handling risks inherent to command-line and shell-interaction interfaces. Current severity, exploitation, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Genexia over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2015-3441HIGH The Parental Control panel in Genexis devices with DRGOS before 1.14.1 allows remote authenticated users to execute arbitrary CLI commands via the (1) start_hour, (2) start_minute, | Jan 5, 2017 | 8.8 | 22 | NO | NO |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Genexia.
Media articles that mention a CVE ID that affects a product developed by Genexia — matched by CVE ID, not by vendor name.